[MeMed in PR Newswire] Beckman Coulter and MeMed to expand access to proven host immune response diagnostic able to distinguish between bacterial and viral infections

BREA, Calif. and HAIFA, Israel, Jan. 31, 2023 /PRNewswire/ — Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers.

Read more here.